Home › Trial NCT00432107
A Study to Assess APO866 for the Treatment of Advanced Melanoma
- Trial IDNCT00432107
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorValerio Therapeutics
- Enrollment25
- Start date2006-07
- ConditionsMelanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.